(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AXUBIQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AXUBIQ

ST13

US500000079279294

Class

5

Filing

79279294

Registration

6093298

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

05/24/2025

Trademark type

Word

Nice classes

5

Filing date

01/13/2020

Registration date

07/07/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/07/2020

Last transaction

05/24/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

CARR,PATRICK C

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Glaxo Group Limited

Representatives

Legal Brand Protection, GSK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; vaccines

Publications

History of USPTO decisions and trademark events.

15 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/23/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/23/2023

GPNX

NOTIFICATION PROCESSED BY IB

10/10/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/18/2020

FIMP

FINAL DISPOSITION PROCESSED

09/17/2020

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

08/06/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

07/07/2020

PUBO

PUBLISHED FOR OPPOSITION

04/21/2020

NPUB

NOTICE OF PUBLICATION

04/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/17/2020

DOCK

ASSIGNED TO EXAMINER

03/15/2020

MAFR

APPLICATION FILING RECEIPT MAILED

02/29/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/25/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/24/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/20/2020

Continuous trademark protection

Get notified about every new filing that threatens AXUBIQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.